Altered Body Composition and Muscle Anabolic, Catabolic and Metabolic Gene Expression in COPD Patients with Elevated Skeletal Muscle Inflammation.

Author(s):  
HR Gosker ◽  
AH Remels ◽  
P Sliwinski ◽  
M Polkey ◽  
J Galdiz ◽  
...  
2007 ◽  
Vol 21 (9) ◽  
pp. 2152-2163 ◽  
Author(s):  
Lily C. Chao ◽  
Zidong Zhang ◽  
Liming Pei ◽  
Tsugumichi Saito ◽  
Peter Tontonoz ◽  
...  

Abstract Innervation is important for normal metabolism in skeletal muscle, including insulin-sensitive glucose uptake. However, the transcription factors that transduce signals from the neuromuscular junction to the nucleus and affect changes in metabolic gene expression are not well defined. We demonstrate here that the orphan nuclear receptor Nur77 is a regulator of gene expression linked to glucose utilization in muscle. In vivo, Nur77 is preferentially expressed in glycolytic compared with oxidative muscle and is responsive to β-adrenergic stimulation. Denervation of rat muscle compromises expression of Nur77 in parallel with that of numerous genes linked to glucose metabolism, including glucose transporter 4 and genes involved in glycolysis, glycogenolysis, and the glycerophosphate shuttle. Ectopic expression of Nur77, either in rat muscle or in C2C12 muscle cells, induces expression of a highly overlapping set of genes, including glucose transporter 4, muscle phosphofructokinase, and glycogen phosphorylase. Furthermore, selective knockdown of Nur77 in rat muscle by small hairpin RNA or genetic deletion of Nur77 in mice reduces the expression of a battery of genes involved in skeletal muscle glucose utilization in vivo. Finally, we show that Nur77 binds the promoter regions of multiple genes involved in glucose metabolism in muscle. These results identify Nur77 as a potential mediator of neuromuscular signaling in the control of metabolic gene expression.


2011 ◽  
Vol 110 (5) ◽  
pp. 1204-1210 ◽  
Author(s):  
Yun Chau Long ◽  
Emil Kostovski ◽  
Hanneke Boon ◽  
Nils Hjeltnes ◽  
Anna Krook ◽  
...  

Skeletal muscle plays an important role in the regulation of energy homeostasis; therefore, the ability of skeletal muscle to adapt and alter metabolic gene expression in response to changes in physiological demands is critical for energy balance. Individuals with cervical spinal cord lesions are characterized by tetraplegia, impaired thermoregulation, and altered skeletal muscle morphology. We characterized skeletal muscle metabolic gene expression patterns, as well as protein content, in these individuals to assess the impact of spinal cord injury on critical determinants of skeletal muscle metabolism. Our results demonstrate that mRNA levels and protein expression of skeletal muscle genes essential for glucose storage are reduced, whereas expression of glycolytic genes is reciprocally increased in individuals with spinal cord injury. Furthermore, expression of genes essential for lipid oxidation is coordinately reduced in spinal cord injured subjects, consistent with a marked reduction of mitochondrial proteins. Thus spinal cord injury resulted in a profound and tightly coordinated change in skeletal muscle metabolic gene expression program that is associated with the aberrant metabolic features of the tissue.


2010 ◽  
Vol 4 ◽  
pp. S63
Author(s):  
Marianne Diaz ◽  
Nick Martel ◽  
Steve Myers ◽  
Rebecca Fitzsimmons ◽  
Michael Pearen ◽  
...  

2015 ◽  
Vol 308 (9) ◽  
pp. H1078-H1085 ◽  
Author(s):  
Cynthia Zizola ◽  
Peter J. Kennel ◽  
Hirokazu Akashi ◽  
Ruiping Ji ◽  
Estibaliz Castillero ◽  
...  

Exercise intolerance in heart failure has been linked to impaired skeletal muscle oxidative capacity. Oxidative metabolism and exercise capacity are regulated by PPARδ signaling. We hypothesized that PPARδ stimulation reverts skeletal muscle oxidative dysfunction. Myocardial infarction (MI) was induced in C57BL/6 mice and the development of ventricular dysfunction was monitored over 8 wk. Mice were randomized to the PPARδ agonist GW501516 (5 mg/kg body wt per day for 4 wk) or placebo 8 wk post-MI. Muscle function was assessed through running tests and grip strength measurements. In muscle, we analyzed muscle fiber cross-sectional area and fiber types, metabolic gene expression, fatty acid (FA) oxidation and ATP content. Signaling pathways were studied in C2C12 myotubes. FA oxidation and ATP levels decreased in muscle from MI mice compared with sham- operated mice. GW501516 administration increased oleic acid oxidation levels in skeletal muscle of the treated MI group compared with placebo treatment. This was accompanied by transcriptional changes including increased CPT1 expression. Further, the PPARδ-agonist improved running endurance compared with placebo. Cell culture experiments revealed protective effects of GW501516 against the cytokine-induced decrease of FA oxidation and changes in metabolic gene expression. Skeletal muscle dysfunction in HF is associated with impaired PPARδ signaling and treatment with the PPARδ agonist GW501516 corrects oxidative capacity and FA metabolism and improves exercise capacity in mice with LV dysfunction. Pharmacological activation of PPARδ signaling could be an attractive therapeutic intervention to counteract the progressive skeletal muscle dysfunction in HF.


2011 ◽  
Vol 58 (1) ◽  
pp. 19-24 ◽  
Author(s):  
Paul B. Tisdale ◽  
Andrew J. Bennett ◽  
Nandini Seevaratnam ◽  
Ian A. Macdonald ◽  
Kostas Tsintzas

Sign in / Sign up

Export Citation Format

Share Document